Post by
maybe111 on Feb 04, 2021 3:39pm
this is the problem
A biosensor is a sensor that uses biological selectivity to limit its perception to particular key molecules and can be defined as an analytical device possessing a biological or biologically derived sensing element integrated with or associated closely with a physicochemical transducer. In the future it is likely that a number of key developments in therapeutic monitoring and intelligent drug delivery will rely on real-time feedback information in order to deliver an appropriate response. However due to issues of integration and the fragility and unreliability of the bio-molecule, biosensors are currently unable to fulfil this role.
What the claim in the last post is that they have been able to observe the virus being trapped.
Comment by
Bvukmanic on Feb 05, 2021 11:55am
How much will it cost to manufacture a MIP and incorporate into a mask? Margins? Rapid LFA tests can cost less than $1. Might be less expensive to buy N95 masks and test every day, than what they are proposing. Is their MIP mask more effective at trapping particles than a N95?
Comment by
up2005 on Feb 05, 2021 10:04pm
Just get it done. Then an earlier post, (will have to look back) stated SIXW is making (2) Affinity systems per month with a projected $ 100,000.00/month revenue stream. Where is that reported? Gluckman has not provided license revenues. All we do is burn through the cash.
Comment by
maybe111 on Feb 08, 2021 12:51pm
why then are they working with the University of Alberta? If I am the goof, as you say, and I am quite willing to accept that fact, But your response suggests to me it is you that are predisposed to something that is wrong, not I. Might you be the goof? Is their CEO a goof also?
Comment by
lscfa on Feb 09, 2021 11:23am
Forget the mask idea. The AIMPs test strips are the solution. Anyone know if it works with samples of breath, mucus swab, blood, etc?